Young V R, Pelletier V A
School of Science, Massachusetts Institute of Technology, Cambridge 02139.
J Nutr. 1989 Dec;119(12 Suppl):1799-809. doi: 10.1093/jn/119.12_Suppl.1799.
The purpose of this paper is to attempt to define the upper limit of the safe range of protein intake, with particular reference to the protein content of prepared fixed-formulas used for feeding healthy, term infants. For discussion purposes we use the current upper limit proposed by the U.S. Food and Drug Administration (FDA), namely, 4.5 g protein per 100 kcal, as our initial reference level. To help reach a conclusion, the concept and definitions of nutritional adaptation and accommodation are considered, followed by a brief review of selected studies in full-term infants fed varying levels of protein intake. Based on growth and blood biochemical data, principally plasma free amino acid levels, we conclude that the currently proposed FDA upper limit is probably too high. The available data support a recommendation for lowering the value to about 3.5 g of protein per 100 kcal. Concerns for renal solute load (RSL) may require a further, desirable refinement in the value proposed. Indeed RSL should perhaps serve as the primary basis for establishing a rational and safe upper limit for the protein content of prepared fixed-formula diets for the very young, healthy infant.
本文旨在尝试界定蛋白质摄入量安全范围的上限,尤其涉及用于喂养健康足月儿的预制固定配方奶粉的蛋白质含量。为便于讨论,我们采用美国食品药品监督管理局(FDA)提出的当前上限,即每100千卡4.5克蛋白质,作为我们的初始参考水平。为得出结论,我们考虑了营养适应和调节的概念及定义,随后简要回顾了对摄入不同蛋白质水平的足月儿的选定研究。基于生长和血液生化数据,主要是血浆游离氨基酸水平,我们得出结论,FDA目前提议的上限可能过高。现有数据支持将该值降至每100千卡约3.5克蛋白质的建议。对肾溶质负荷(RSL)的担忧可能需要对提议的值进行进一步的合理细化。实际上,RSL或许应作为为非常年幼的健康婴儿确定预制固定配方奶粉饮食蛋白质含量合理且安全上限的主要依据。